Bristol-Myers Squibb Company
BMY
$48.46
$0.561.17%
NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -9.24% | 3.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -9.24% | 3.78% | |||
| Cost of Revenue | -6.04% | 12.46% | |||
| Gross Profit | -10.37% | 1.04% | |||
| SG&A Expenses | -14.63% | -10.96% | |||
| Depreciation & Amortization | -50.97% | -29.63% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -19.70% | -1.55% | |||
| Operating Income | 26.42% | 27.31% | |||
| Income Before Tax | 1,597.71% | -89.56% | |||
| Income Tax Expenses | 414.14% | -78.52% | |||
| Earnings from Continuing Operations | 3,139.47% | -93.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -50.00% | 0.00% | |||
| Net Income | 3,311.11% | -94.05% | |||
| EBIT | 26.42% | 27.31% | |||
| EBITDA | -9.79% | -3.79% | |||
| EPS Basic | 3,306.48% | -94.05% | |||
| Normalized Basic EPS | 50.22% | 5.62% | |||
| EPS Diluted | 3,280.28% | -94.05% | |||
| Normalized Diluted EPS | 50.14% | 5.37% | |||
| Average Basic Shares Outstanding | 0.10% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.15% | 0.30% | |||
| Dividend Per Share | 0.00% | 3.33% | |||
| Payout Ratio | -0.97% | 15.85% | |||